Filtros de búsqueda

Lista de obras de Paul M Moseley

Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers

artículo científico publicado en 2014

Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells

artículo científico publicado en 2013

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

artículo científico publicado en 2013

Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study

artículo científico publicado en 2015

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay

artículo científico publicado en 2014

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer

artículo científico publicado en 2015

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.

artículo científico publicado en 2015

Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.

artículo científico publicado en 2014

Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer

artículo científico publicado en 2014

DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts

artículo científico publicado en 2014

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers

artículo científico publicado en 2015

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

artículo científico publicado en 2019

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.

artículo científico publicado en 2017

Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer

artículo científico publicado en 2014

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

artículo científico publicado en 2014

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

artículo científico publicado en 2015

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer

artículo científico publicado en 2014

High mobility group protein B1 is a predictor of poor survival in ovarian cancer.

artículo científico publicado en 2017

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer

article

Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?

artículo científico publicado en 2014

Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer

artículo científico publicado en 2014

RECQL4 helicase has oncogenic potential in sporadic breast cancers

artículo científico publicado en 2015

SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.

artículo científico publicado en 2016

Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy

artículo científico publicado en 2013

Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy

artículo científico publicado en 2014

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

artículo científico publicado en 2018

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.

artículo científico publicado en 2017

The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response

artículo científico publicado en 2018

Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer

artículo científico publicado en 2010

Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.

artículo científico publicado en 2015

Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda